Amanta Healthcare IPO: Check key dates, objectives, and all you need to know

Amanta Healthcare IPO: The initial public offering of pharmaceutical player Amanta Healthcare Ltd will open for subscription on September 1. The issue will conclude on September 3. The company has not announced the price band yet.

The bidding for anchor investors will occur on August 29.

The initial share sale is exclusively a fresh issuance of 1,00,00,000 shares. There is no offer for sale component.

The net proceeds from the issue will be used for the following objects:

• Funding capital expenditure needs for civil construction work and purchase of equipment
• General corporate purposes

The company has reserved 50% of the net issue for qualified institutional buyers, 35% for retail investors and 15% for non-institutional investors.

Amanta Healthcare IPO timeline: Allotment and listing dates

Beeline Capital Advisors Pvt Ltd is the IPO's book-running lead manager, while MUFG Intime India (formerly Link Intime India) is the registrar.

Amanta Healthcare is a drugmaker involved in developing, manufacturing and marketing several sterile liquid products – parenteral products packed in plastic containers with Injection Stretch Blow Moulding technology and Aseptic Blow-Fill-Seal. It makes large-volume parenterals and small-volume parenterals in six therapeutic segments.

It also manufactures medical devices, IV fluid, formulations, ophthalmic, diluents, respiratory care and irrigation solutions in the therapeutic segment and products like irrigation, first-aid solution and eye lubricants.

It markets products via three strategic business units: National sales, international sales and product partnering with foreign and Indian pharmaceutical firms.

"We manufacture a diverse generics product portfolio of over 45 products and market them under our own brands in the Indian market through a network of over 320 distributors and stockists," the company said in its red herring prospectus.